Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
European Journal of Immunology
|
April 27, 2007
Erythropoietin enhances immune responses in mice
Odelia Katz, Lidor Gil, Lilach Lifshitz, et al.
Bone Reports
|
December 24, 2025
Erythropoietin and bone health: Single high-dose administration triggers bone loss in mice
Anton Gorodov, Albert Kolomansky, Lior Lezerovich, et al.
Experimental Hematology
|
October 31, 2012
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients
Howard S Oster, Sara Prutchi-Sagiv, Ora Halutz, et al.
The Journal of Biological Chemistry
|
December 9, 2003
Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity
Eran Barzilay, Nathalie Ben-Califa, Lia Supino-Rosin, et al.
The Journal of Biological Chemistry
|
May 9, 2002
A functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residues
Robin Ketteler, Achim C Heinrich, Julia K Offe, et al.
Leukemia Research
|
November 22, 2016
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes
Naamit Deshet-Unger, Howard S Oster, Sara Prutchi-Sagiv, et al.
Bone Research
|
September 14, 2021
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
Martina Rauner, Marta Murray, Sylvia Thiele, et al.
The Journal of Endocrinology
|
January 12, 2010
Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models
Odelia Katz, Matthew Stuible, Nathalia Golishevski, et al.
British Journal of Haematology
|
November 17, 2006
Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
Sara Prutchi-Sagiv, Natalia Golishevsky, Howard S Oster, et al.
International Journal of Molecular Sciences
|
May 13, 2023
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
Jennifer Ana Iden, Bitya Raphael-Mizrahi, Aaron Naim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
European Journal of Immunology
|
April 27, 2007
Erythropoietin enhances immune responses in mice
Odelia Katz, Lidor Gil, Lilach Lifshitz, et al.
Bone Reports
|
December 24, 2025
Erythropoietin and bone health: Single high-dose administration triggers bone loss in mice
Anton Gorodov, Albert Kolomansky, Lior Lezerovich, et al.
Experimental Hematology
|
October 31, 2012
Erythropoietin treatment is associated with an augmented immune response to the influenza vaccine in hematologic patients
Howard S Oster, Sara Prutchi-Sagiv, Ora Halutz, et al.
The Journal of Biological Chemistry
|
December 9, 2003
Geldanamycin-associated inhibition of intracellular trafficking is attributed to a co-purified activity
Eran Barzilay, Nathalie Ben-Califa, Lia Supino-Rosin, et al.
The Journal of Biological Chemistry
|
May 9, 2002
A functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residues
Robin Ketteler, Achim C Heinrich, Julia K Offe, et al.
Leukemia Research
|
November 22, 2016
Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes
Naamit Deshet-Unger, Howard S Oster, Sara Prutchi-Sagiv, et al.
Bone Research
|
September 14, 2021
Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
Martina Rauner, Marta Murray, Sylvia Thiele, et al.
The Journal of Endocrinology
|
January 12, 2010
Erythropoietin treatment leads to reduced blood glucose levels and body mass: insights from murine models
Odelia Katz, Matthew Stuible, Nathalia Golishevski, et al.
British Journal of Haematology
|
November 17, 2006
Erythropoietin treatment in advanced multiple myeloma is associated with improved immunological functions: could it be beneficial in early disease?
Sara Prutchi-Sagiv, Natalia Golishevsky, Howard S Oster, et al.
International Journal of Molecular Sciences
|
May 13, 2023
The Anti-Tumorigenic Role of Cannabinoid Receptor 2 in Non-Melanoma Skin Cancer
Jennifer Ana Iden, Bitya Raphael-Mizrahi, Aaron Naim, et al.
Page
of 6